SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACUS ACUSPHERE INC -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (33)10/25/2008 11:44:01 AM
From: rkrw  Respond to of 41
 
An injectable celebrex for short term hospital use could be an interesting product, too bad its so early.

ceph is historically pretty shrewd, they must also see the chance of imagify approval being higher than the market thinks, but even if not they still win.



To: fred hayes who wrote (33)11/4/2008 5:12:10 PM
From: jpbrody  Read Replies (1) | Respond to of 41
 
Acusphere filed a revised 8k. The Imagify royalty rate is 20%.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News